FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
Immune Design (NASDAQ: IMDZ) reported Q4 EPS of ($0.60), $0.06 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.06 million.
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
... More
